WGS
HEALTHCAREGeneDx Holdings Corp.
AI Insight
What's Moving WGS Today?
No stock-specific AI insight has been generated for WGS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$32.21$170.87
$62.06
Fundamentals
Market Cap$1.8B
P/E Ratio—
EPS$-2.70
Dividend Yield—
Dividend / Share—
ROE-30.4%
Profit Margin-17.6%
Debt / Equity—
Trading
Volume351K
Avg Volume (10D)—
Shares Outstanding29.7M
WGS News
35 articles- Portnoy Law Firm Announces Class Action on Behalf of GeneDX Holdings, Corp. InvestorsGlobeNewswire·Jul 21, 2026
- WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law FirmMorningstar·Jul 21, 2026
- GeneDx Holdings Corp. (WGS) Slid as Revenue Fell Short of ExpectationsYahoo Finance·Jul 21, 2026
- WGS Shareholder Alert: GeneDx Holdings Corp. Securities Accessibility: Skip TopNav Consumer Products and Services News Automobiles and Parts News Food & Beverage News Home Goods & Construction News Leisure Goods News Media & Entertainment News Personal Care News Retail News Travel and Leisure News Energy News Alternative Energy News Oil Gas and Coal News Chemicals News Banks & Financial Services News Banking News Closed-End Investments News Finance and Credit Services News Investment Banking and Brokerage Services News Insurance News Real Estate & REITs News Healthcare News Healthcare Providers News Medical Equipment News Medical Supplies and Services News Biotechnology News Pharmaceuticals News Cannabis Producers News Industrials and Utilities News Aerospace and Defense News Construction and Materials News Utilities News Industrials News Metals & Mining News Technology and Telecom News Software News IT Services News Semiconductors News Electronic Components & Equipment News Computer Hardware News Telecom Equipment News Telecom Services News More Browse the Latest News WGS Shareholder Alert: GeneDx Holdings Corp. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky Deadline Alert: Understanding Lead Plaintiff Selection Under the PSLRA in the GeneDx Holdings Corp. Securities Class Action Where Investors Lost $33.42 Per ShareGlobeNewswire·Jul 20, 2026
- GeneDx Holdings Corp. (WGS) Fell Following a Significant Cut in 2026 GuidanceYahoo Finance·Jul 17, 2026
- GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026Yahoo Finance·Jul 16, 2026
- GeneDx Holdings Corp. Class Action Lawsuit Seeks RecoveryGlobeNewswire·Jul 16, 2026
- Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the FirmGlobeNewswire·Jul 13, 2026
- GeneDx (WGS) director adds 3,576 shares and 4,248 new RSUs in Form 4Stock Titan·Jun 24, 2026
- What a $227,000 GeneDx Insider Sale Means as Revenue Climbs 17%Motley Fool·Jun 23, 2026
- Securities Fraud Class Action Filed Against GeneDx Holdings Corp. (WGS) – Levi & Korsinsky Reminds Investors of August 3, 2026ACCESS Newswire·Jun 20, 2026
- GeneDx (WGS) CEO Stueland sells 10,501 shares in tax sell-to-coverStock Titan·Jun 19, 2026
- GeneDx Holdings (WGS) Faces Securities Class Action After 49% Drop, 94% Write-off Related to Fabric Genomics Acquisition - HBSSTradingView·Jun 19, 2026
- GeneDx Names Mark Gardner President to Lead Its Next Phase of Scale and GrowthYahoo Finance·Jun 16, 2026
- Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor HarmGlobeNewswire·Jun 15, 2026
- Hedge Funder Eli Casdin Is Loading up on GeneDx SharesMotley Fool·Jun 11, 2026
- Bragar Eagel & Squire, P.C. Announces that a Class ActionGlobeNewswire·Jun 8, 2026
- Casdin fund adds 200,000 GeneDx (WGS) shares in open-market buysStock Titan·Jun 8, 2026
- GeneDx Holdings (WGS) Valuation After Q1 2026 Earnings Miss Guidance Cut And Legal ScrutinyYahoo Finance·Jun 6, 2026
- From Industry Titans to Tiny Fish: 3 Key Stocks Insiders are TradingMarketbeat·Jun 6, 2026
- WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with the Schall Law FirmBusiness Wire·Jun 5, 2026
- This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%The Motley Fool·May 23, 2026
- Ashland, GeneDX Holdings, and 3 More Stocks See Action From Activist InvestorsYahoo Finance·May 22, 2026
- Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares?Motley Fool·May 21, 2026
- Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & ShareholderYahoo Finance·May 20, 2026
- A Look At GeneDx Holdings (WGS) Valuation After Earnings Miss Guidance Cut And Securities InvestigationYahoo Finance·May 16, 2026
- Corvex-linked funds boost GeneDx (WGS) stake with 351K-share open-market buyStock Titan·May 15, 2026
- Casdin and Meister report 12% and 17.9% GeneDx (WGS) stakesStock Titan·May 15, 2026
- GeneDx (WGS) Fell Despite Continued Execution ImprovementYahoo Finance·May 14, 2026
- The 'Alarming' Results That Caused GeneDx Stock To Plummet 49%Yahoo Finance·May 5, 2026
- Why GeneDX Stock Is Plummeting TodayMotley Fool·May 5, 2026
- Does GeneDx’s Guidance Cut And Core Shift Reshape The Bull Case For GeneDx Holdings (WGS)?Yahoo Finance·May 5, 2026
- GeneDx Holdings Corp. Q1 2026 Earnings Call SummaryMoby·May 5, 2026
- GeneDx Q1 Earnings Call HighlightsMarketbeat·May 5, 2026
- Cathie Wood Goes Bargain Hunting: 3 Stocks She Just BoughtThe Motley Fool·Apr 8, 2026
All 35 articles loaded
Price Data
Open$61.50
Previous Close$61.65
Day High$62.72
Day Low$60.34
52 Week High$170.87
52 Week Low$32.21
52-Week Range
$32.21$170.87
$62.06
Fundamentals
Market Cap$1.8B
P/E Ratio—
EPS$-2.70
Dividend Yield—
Dividend / Share—
ROE-30.4%
Profit Margin-17.6%
Debt / Equity—
Trading
Volume351K
Avg Volume (10D)—
Shares Outstanding29.7M
About GeneDx Holdings Corp.
Sema4 Holdings Corp. The company is headquartered in Stamford, Connecticut.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—